These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 13372947)

  • 21. Non-carbapenem therapy of urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae.
    de La Blanchardière A; Dargère S; Guérin F; Daurel C; Saint-Lorant G; Verdon R; Cattoir V
    Med Mal Infect; 2015 May; 45(5):169-72. PubMed ID: 25845927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic effects of paracolon bacteremia.
    NELSON RM
    Ann Surg; 1951 Nov; 134(5):885-96. PubMed ID: 14885955
    [No Abstract]   [Full Text] [Related]  

  • 23. On the occurrence and the significance of paracolon bacteria in the Netherlands.
    HEYL JG
    Antonie Van Leeuwenhoek; 1954; 20(4):406-14. PubMed ID: 13218561
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mannite-negative paracolon bacteria].
    SHTIBEN VD
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Dec; (12):73-5. PubMed ID: 13300925
    [No Abstract]   [Full Text] [Related]  

  • 25. Antigenic studies of a group of paracolon bacteria (32011 group).
    EVELAND WC; FABER JE
    J Infect Dis; 1953; 93(3):226-35. PubMed ID: 13109236
    [No Abstract]   [Full Text] [Related]  

  • 26. Urinary tract infection caused by fluoroquinolone- and cephem-resistant Enterobacteriaceae.
    Muratani T; Matsumoto T
    Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S10-3. PubMed ID: 16829056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some observations on the antigenic structure of trichloroacetic acid extracts in Escherichia and the Paracolon group.
    MACPHERSON CR
    J Gen Microbiol; 1956 Jul; 14(3):520-6. PubMed ID: 13346015
    [No Abstract]   [Full Text] [Related]  

  • 28. Occurrence of paracolon bacteria in a tropical marine environment and their classification.
    SREENIVASAN A; VENKATARAMAN R
    Nature; 1956 Sep; 178(4532):547. PubMed ID: 13358800
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antigenic relationship of paracolon bacteria to Shigella dysenteriae].
    LACHOWICZ T; CHODOROWSKI E
    Med Dosw Mikrobiol; 1955; 7(3):233-42. PubMed ID: 13253260
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental studies with a member of the Paracolon escherichia group producing human panophthalmitis.
    GAINOR C; BROWN JW; SWANEY LM
    Am J Ophthalmol; 1952 Aug; 35(8):1196-201. PubMed ID: 14943771
    [No Abstract]   [Full Text] [Related]  

  • 31. Reducing Carbapenem Exposure: Extended-Spectrum β-Lactamase Catheter-Associated Urinary Tract Infection Management.
    Holt S; Grant M; Thompson-Brazill KA
    Crit Care Nurse; 2017 Oct; 37(5):78-84. PubMed ID: 28966198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and clinical evaluation of ofloxacin in urinary tract infection and enteric fever.
    Tanphaichitra D; Srimuang S
    Drugs Exp Clin Res; 1988; 14(8):529-31. PubMed ID: 3266853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fosfomycin in chronic urinary infections.
    Allona A; Díaz Cabrera JA; Manchado P
    Chemotherapy; 1977; 23 Suppl 1():267-74. PubMed ID: 851501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of family physicians' practices in case of urinary tract infections caused by enterobacteriaceae secreting extended-spectrum-beta-lactamase.
    Miclot C; Antoniotti G; Forestier E
    Med Mal Infect; 2015 Mar; 45(3):78-83. PubMed ID: 25676475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasmid-mediated quinolone resistance genes in Enterobacteriaceae isolates associated with community and nosocomial urinary tract infection in East London, UK.
    Amin AK; Wareham DW
    Int J Antimicrob Agents; 2009 Nov; 34(5):490-1. PubMed ID: 19261447
    [No Abstract]   [Full Text] [Related]  

  • 37. The differentiation of Enterobacteriaceae infecting the urinary tract: A study in male paraplegics.
    Milner PF
    J Clin Pathol; 1963 Jan; 16(1):39-45. PubMed ID: 16810994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance to oral antibiotics in 4569 Gram-negative rods isolated from urinary tract infection in children.
    Calzi A; Grignolo S; Caviglia I; Calevo MG; Losurdo G; Piaggio G; Bandettini R; Castagnola E
    Eur J Pediatr; 2016 Sep; 175(9):1219-1225. PubMed ID: 27558493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the occurrence of paracolon and non-lactose fermenting enteric bacteria in general hospital patients.
    HARE RA; BEAMER PR
    N C Med J; 1953 Mar; 14(3):105-7. PubMed ID: 13037095
    [No Abstract]   [Full Text] [Related]  

  • 40. Activity of omadacycline tested against Enterobacteriaceae causing urinary tract infections from a global surveillance program (2014).
    Pfaller MA; Rhomberg PR; Huband MD; Flamm RK
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):179-183. PubMed ID: 29571839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.